These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15018704)

  • 1. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.
    Si Z; Gorry P; Babcock G; Owens CM; Cayabyab M; Phan N; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):163-73. PubMed ID: 15018704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).
    Cayabyab M; Karlsson GB; Etemad-Moghadam BA; Hofmann W; Steenbeke T; Halloran M; Fanton JW; Axthelm MK; Letvin NL; Sodroski JG
    J Virol; 1999 Feb; 73(2):976-84. PubMed ID: 9882298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.
    Si Z; Cayabyab M; Sodroski J
    J Virol; 2001 May; 75(9):4208-18. PubMed ID: 11287570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
    Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.
    Ye Y; Si ZH; Moore JP; Sodroski J
    J Virol; 2000 Dec; 74(24):11955-62. PubMed ID: 11090196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.
    Etemad-Moghadam B; Sun Y; Nicholson EK; Fernandes M; Liou K; Gomila R; Lee J; Sodroski J
    J Virol; 2000 May; 74(9):4433-40. PubMed ID: 10756060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    Vaccine; 2002 May; 20(15):1934-7. PubMed ID: 11983249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.
    Chakrabarti LA; Ivanovic T; Cheng-Mayer C
    J Virol; 2002 Feb; 76(4):1588-99. PubMed ID: 11799153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
    J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
    Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
    Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
    Imamichi H; Igarashi T; Imamichi T; Donau OK; Endo Y; Nishimura Y; Willey RL; Suffredini AF; Lane HC; Martin MA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13813-8. PubMed ID: 12370415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
    Liao HX; Etemad-Moghadam B; Montefiori DC; Sun Y; Sodroski J; Scearce RM; Doms RW; Thomasch JR; Robinson S; Letvin NL; Haynes BF
    J Virol; 2000 Jan; 74(1):254-63. PubMed ID: 10590113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.
    Li Y; Dittmer U; Wang Y; Song J; Sun B; Yang R
    Virol Sin; 2016 Jun; 31(3):207-18. PubMed ID: 27117672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity.
    Si Z; Phan N; Kiprilov E; Sodroski J
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):217-26. PubMed ID: 12689414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain.
    Marcon L; Sodroski J
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):441-7. PubMed ID: 9100985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.
    Balfe P; Shapiro S; Hsu M; Buckner C; Harouse JM; Cheng-Mayer C
    Virology; 2004 Jan; 318(1):267-79. PubMed ID: 14972553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
    Cayabyab M; Rohne D; Pollakis G; Mische C; Messele T; Abebe A; Etemad-Moghadam B; Yang P; Henson S; Axthelm M; Goudsmit J; Letvin NL; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):27-40. PubMed ID: 15000696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.